Diff Profiles › MTBLS280_0002_00000001

Control_vs_Immune_Tolerant

Control vs Immune Tolerant

p-value ≤ 0.05 2 significant 2025-09-26 00:00:00 Study: MTBLS280
26 Total Features
2 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS280_0002_00000001
Linked study
MTBLS280 — Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
Comparison
Control vs Immune Tolerant
Group A
Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.
Group B
Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.
Total features tested
26
Significant features
2
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
MPSPNFAQQQMFLK-UHFFFAOYSA-N 3-(nonanoyloxy)-4-(trimethylammonio)butanoate up 2.808 0.00029
MJLXQSQYKZWZCB-UTJQPWESSA-N linoleylcarnitine down 0.5145 0.000901